JAZF1-AS1
|
|
JAZF1 antisense RNA 1
|
|
1
|
1.000 |
0.115 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2011 |
2011 |
Entrez Id: |
100287272 |
Gene Symbol: |
USP8P1 |
USP8P1
|
|
USP8 pseudogene 1
|
|
7
|
0.805 |
0.269 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
PSMB8-AS1
|
|
PSMB8 antisense RNA 1 (head to head)
|
|
2
|
0.839 |
0.385 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2007 |
MSH5-SAPCD1
|
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
8
|
0.760 |
0.423 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
ATP6V1G2-DDX39B
|
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
12
|
0.769 |
0.423 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
PPT2-EGFL8
|
|
PPT2-EGFL8 readthrough (NMD candidate)
|
|
9
|
0.792 |
0.462 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2007 |
TSBP1-AS1
|
|
TSBP1 and BTNL2 antisense RNA 1
|
|
39
|
0.638 |
0.692 |
|
0.100 |
None
|
1.000 |
1
|
30
|
2007 |
2015 |
Entrez Id: |
10255 |
Gene Symbol: |
HCG9 |
HCG9
|
|
HLA complex group 9
|
|
9
|
0.700 |
0.500 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
LINC02357
|
|
long intergenic non-protein coding RNA 2357
|
|
3
|
0.805 |
0.231 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2009 |
2009 |
LINC02829
|
|
long intergenic non-protein coding RNA 2829
|
|
2
|
0.890 |
0.231 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
LINC02571
|
|
long intergenic non-protein coding RNA 2571
|
|
18
|
0.743 |
0.500 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2007 |
EHMT2-AS1
|
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
7
|
0.780 |
0.462 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2007 |
AQP4-AS1
|
|
AQP4 antisense RNA 1
|
|
3
|
0.751 |
0.577 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2010 |
2010 |
Entrez Id: |
267015 |
Gene Symbol: |
HLA-S |
HLA-S
|
|
major histocompatibility complex, class I, S (pseudogene)
|
|
2
|
0.931 |
0.192 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
HLA-DRB9
|
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
21
|
0.682 |
0.654 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2019 |
Entrez Id: |
3139 |
Gene Symbol: |
HLA-L |
HLA-L
|
|
major histocompatibility complex, class I, L (pseudogene)
|
|
3
|
0.861 |
0.269 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2007 |
COL11A2P1
|
|
collagen type XI alpha 2 pseudogene 1
|
|
6
|
0.805 |
0.462 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
LINC02649
|
|
long intergenic non-protein coding RNA 2649
|
|
6
|
0.792 |
0.308 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2008 |
2008 |
LINC00243
|
|
long intergenic non-protein coding RNA 243
|
|
15
|
0.729 |
0.423 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2015 |
TRIM26BP
|
|
tripartite motif containing 26B, pseudogene
|
|
4
|
0.861 |
0.269 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
Entrez Id: |
414777 |
Gene Symbol: |
HCG18 |
HCG18
|
|
HLA complex group 18
|
|
12
|
0.722 |
0.538 |
|
0.120 |
None
|
1.000 |
1
|
2
|
2007 |
2018 |
Entrez Id: |
414778 |
Gene Symbol: |
HCG17 |
HCG17
|
|
HLA complex group 17
|
|
12
|
0.769 |
0.346 |
|
0.100 |
None
|
1.000 |
1
|
4
|
2007 |
2007 |
Entrez Id: |
50854 |
Gene Symbol: |
SNHG32 |
SNHG32
|
|
small nucleolar RNA host gene 32
|
|
8
|
0.805 |
0.308 |
2.4E-02 |
0.100 |
None
|
1.000 |
1
|
1
|
2007 |
2007 |
Entrez Id: |
55384 |
Gene Symbol: |
MEG3 |
MEG3
|
|
maternally expressed 3
|
|
1
|
0.471 |
0.846 |
|
0.110 |
None
|
1.000 |
1
|
1
|
2010 |
2015 |
HLA-DPA2
|
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
6
|
0.780 |
0.538 |
|
0.100 |
None
|
1.000 |
1
|
2
|
2007 |
2007 |